References

Cancer statistics, 2026

2026 · External reference

No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236

10.1016/j.ijrobp.2013.12.050 · 2014 · External reference

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

10.1016/s1470-2045(15)70168-3 · 2015 · External reference

10.1016/s1470-2045(14)71207-0

10.1016/s1470-2045(14)71207-0 · 2015 · External reference

PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer

10.1200/jco.2015.64.8824 · 2016 · External reference

Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy

10.1016/j.radonc.2013.08.017 · 2013 · External reference

Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer

10.1200/jco.2013.51.5353 · 2013 · External reference

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

10.1200/jco.2006.07.5937 · 2006 · External reference

Biology of radiation-induced lung injury

10.1016/j.semradonc.2020.11.006 · 2021 · External reference

Radiation-induced lung injury: current evidence

10.1186/s12890-020-01376-4 · 2021 · External reference

Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis

10.1016/j.ijrobp.2012.04.043 · 2013 · External reference

Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients

10.1016/j.radonc.2017.04.017 · 2017 · External reference

Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy

10.1016/j.radonc.2017.09.004 · 2017 · External reference

Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions

10.1016/j.jtho.2020.11.002 · 2021 · External reference

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group

10.1016/j.ijrobp.2010.09.004 · 2012 · External reference

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer

10.1200/jco.2009.26.2543 · 2010 · External reference

Complication probability as assessed from dose-volume histograms

10.2307/3576626 · 1985 · External reference

Integrating multiomics information in deep learning architectures for joint actuarial outcome prediction in non-small cell lung cancer patients after radiation therapy

10.1016/j.ijrobp.2021.01.042 · 2021 · External reference

Deep learning-guided dosimetry for mitigating local failure of patients with non-small cell lung Cancer receiving stereotactic body radiation therapy

10.1016/j.ijrobp.2023.11.059 · 2024 · External reference

Multi-center evaluation of dose conformity in stereotactic body radiotherapy

10.1016/j.phro.2019.08.002 · 2019 · External reference

Quantitative beam optimization for radiotherapy of peripheral lung lesions: a pilot study in stereotactic body radiotherapy

10.1002/acm2.70029 · 2025 · External reference

Risk of target coverage loss for stereotactic body radiotherapy treatment of synchronous lung lesions via single-isocenter volumetric modulated arc therapy

10.1002/acm2.13145 · 2020 · External reference

Single-isocenter versus multiple-isocenters for multiple lung metastases: evaluation of lung dose

10.1016/j.radonc.2021.11.030 · 2022 · External reference

Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy

10.1002/acm2.12500 · 2019 · External reference

SBRT treatment of multiple extracranial oligometastases using a single isocenter with distinct optimizations

2017 · External reference

Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT

10.1002/acm2.12580 · 2019 · External reference

Improving treatment efficiency via photon optimizer (PO) MLC algorithm for synchronous single-isocenter/multiple-lesions VMAT lung SBRT

10.1002/acm2.12721 · 2019 · External reference

Treatment plan technique and quality for single-isocenter stereotactic ablative radiotherapy of multiple lung lesions with volumetric-modulated arc therapy or intensity-modulated radiosurgery

10.3389/fonc.2015.00213 · 2015 · External reference

Conformity index: a review

10.1016/j.ijrobp.2005.09.028 · 2006 · External reference

RayStation: external beam treatment planning system

10.1016/j.meddos.2018.02.013 · 2018 · External reference

Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver

10.1016/j.ijrobp.2010.03.020 · 2011 · External reference

Management of oligometastatic non-small cell lung cancer patients: current controversies and future directions

10.5306/wjco.v10.i10.318 · 2019 · External reference

MRI-linear accelerator radiotherapy systems

10.1016/j.clon.2018.08.003 · 2018 · External reference

The technical design and concept of a PET/CT linac for biology-guided radiotherapy

2021 · External reference

Helical tomotherapy: a fascinating technological concept that has matured into clinical reality

10.1177/153303460800700601 · 2008 · External reference

Improving lung stereotactic body radiation therapy dose conformity using a simple noncoplanar volumetric modulated arc therapy technique

10.1016/j.prro.2025.02.007 · 2025 · External reference

Dosimetric investigation of couch rotation angles in non-coplanar VMAT plans for lung cancer SBRT

10.3389/fonc.2024.1454676 · 2024 · External reference